WATER INDUSTRY FEATURES, INSIGHTS, AND ANALYSIS
-
Putting The National Toxicology Program's Fluoride Review In Context
Despite renewed public concern over fluoride and cognition, the National Toxicology Program’s findings focus on high‑fluoride groundwater conditions — not the controlled levels used in U.S. drinking water systems. Understanding that distinction is critical for utilities navigating policy questions and community expectations.
-
Opinion: Why PFAS Policymakers Should Read Past The Abstract When it comes to drinking water, sound public policy requires sound scientific research. Publication in a prestigious, peer-reviewed journal helps establish legitimacy for scientific claims in public discourse. But science is a social process, scientific standards of evidence vary across disciplines, and peer review does not guarantee validity. For readers who stop at the abstract, these distinctions can be easy to miss.
-
Planting The Seeds Of Inspiration: Eelgrass Restoration
Restoring eelgrass beds is critical because they provide habitat for many kinds of marine life, improve water quality by filtering out pollution, and the plant’s root system stabilizes the sediment on the seafloor, protecting shorelines from erosion.
-
PFAS Are Turning Up In The Great Lakes, Putting Water Supplies At Risk — Here's How They Get There No matter where you live in the U.S., you have likely seen headlines about PFAS being detected in everything from drinking water to fish to milk to human bodies. Now, PFAS are posing a threat to the Great Lakes, one of America’s most vital water resources.
-
Why Too Much Phosphorus In America's Farmland Is Polluting The Country's Water When people think about agricultural pollution, they often picture what is easy to see: fertilizer spreaders crossing fields or muddy runoff after a heavy storm. However, a much more significant threat is quietly and invisibly building in the ground.
-
Water In 2026: The Nexus Of Policy, Technology, And Resilience As water systems become more circular and complex, understanding and managing the subsurface — the hidden half of the water cycle — is becoming a critical enabler of resilience. This article explores the key trends shaping this new reality, from tackling “forever chemicals” to the water strategies redefining heavy industry.
-
PFAS In Pregnant Women's Drinking Water Puts Their Babies At Higher Risk, Study Finds
When pregnant women drink water that comes from wells downstream of sites contaminated with PFAS, known as “forever chemicals,” the risks to their babies’ health substantially increase, a new study found. These risks include the chance of low birth weight, preterm birth, and infant mortality.
-
PFAS Settlements: Debunking The Myths And Revealing What's Really At Stake For Water Utilities Misinformation and confusion could prevent some utilities from benefitting from the aqueous film-forming foam multidistrict litigation (AFFF MDL) settlements. Here are five common myths about the AFFF MDL PFAS settlements and how public water systems can make the most of this unprecedented funding opportunity.
-
When Chemistry Meets Water Innovation
Nobel-winning molecular materials are poised to reinvent purification, desalination, and reuse.
-
Solving The World's Microplastics Problem: 4 Solutions Cities And States Are Trying After Global Treaty Talks Collapsed
Microplastics seem to be everywhere — in the air we breathe, the water we drink, the food we eat. Countries have tried for the past few years to write a global plastics treaty that might reduce human exposure, but the latest negotiations collapsed in August 2025. While U.S. and global solutions seem far off, policies to limit harm from microplastics are gaining traction at the state and local levels.
VIEWS ON THE LATEST REGS
-
In this Q&A, Dr. Elke Süss of Metrohm addresses the urgent need for haloacetic acid testing in response to “one of the most significant updates to EU drinking water monitoring in recent years.”
-
With the U.S. EPA's PFAS rules now in place, utilities are finding themselves with a growing number of questions regarding how to treat these chemicals, the potential costs, and much more. For answers, Water Online's chief editor, Kevin Westerling, hosted an Ask Me Anything session featuring Ken Sansone, Senior Partner at SL Environmental Law Group; Kyle Thompson, National PFAS Lead at Carollo Engineers; and Lauren Weinrich, Principal Scientist at American Water.
-
A Q&A to explain and resolve issues confronting water suppliers as they endeavor to comply with the monitoring requirements of federal PFAS regulations.
-
Assessing what lies ahead in the 10-year race to go lead-free, otherwise known as the Lead and Copper Rule Improvements (LCRI).
-
Many water systems are still tackling the challenge of identifying and compliantly managing galvanized and galvanized-requiring-replacement (GRR) service lines.
MORE WATER INDUSTRY FEATURES
-
How GenAI Is Supercharging Digital Transformation For Rural Water Utilities Across The United States
From streamlining data workflows to preserving decades of field knowledge, utilities of all sizes are demonstrating that GenAI isn’t just a technology trend — it’s a workforce enabler.
-
Chlorine sensor waste streams cause massive water loss and costs. The Halogen MP-5 sensor eliminates waste, reduces maintenance, and improves efficiency—offering a breakthrough in sustainable water monitoring.
-
Amid scrutiny of the financial conflicts of interest in biomedical research, new federal rules aim to improve transparency and preserve the integrity of publicly funded research.
-
Explore the technical hurdles of APOE-targeted development and the precision tools—including target proteins and pre-formed fibrils (PFFs)—required to bridge the gap from risk identification to commercial success.
-
Like a referee in a contest, advanced analytical methods are essential to mediate the push and pull of different factors influencing therapeutic efficacy.
-
Learn how a comprehensive investigation and systems-level bio-decontamination strategy successfully eliminated persistent mold contamination in a vaccine manufacturing facility's high-risk area.
-
Poor solubility of active pharmaceutical ingredients can hinder drug effectiveness. Learn how innovative formulation strategies enhance solubility and bioavailability to improve therapeutic outcomes for challenging drug candidates.
-
Clinical medical writing for gene therapy regulatory documents is a demanding, detail-oriented task that diverges significantly from medical writing for more traditional therapies.
-
When developing combination products or evaluating primary packaging for drug products one must evaluate the performance of the devices and the packaging to ensure that they are fit-for-purpose.
-
Proper connector care ensures measurement accuracy and reliability. Learn how color-coded connectors, inspections, and storage best practices maintain phase stability and protect your RF test setups.
-
In the picturesque village of Arzacq-Arraziguet in southwestern France, a critical water pipeline repair showcased the efficiency of modern tools and techniques.
-
EV production must align with CMC and regulatory standards before it can reach its full potential. This study compares conditioned medium across scalable platforms to optimize EV manufacturing for the clinic.
-
Explore strategies to maximize drug product recovery during sterile filtration, minimize hold-up volume, and reduce dilution after PUPSIT to ensure higher yield, improved efficiency, and less waste.
-
Engineers and project managers must take a complete cradle-to-grave approach when considering which technologies to implement as well as which vendors to partner with for their PFAS solution.
-
Biologics are transforming medicine, with semaglutide leading the way. Discover how an automated LC-MS/MS workflow enables high-sensitivity quantification of peptides in plasma.
-
Balancing robust analytics and clinical readiness is key for early-phase pDNA and mRNA therapeutics amid structural complexity and regulatory challenges.
-
The evolving field of viral vector production, driven by advances in gene and cell therapies, is facing increasing regulatory scrutiny and analytical demands.
-
Regulators are increasingly favoring in vitro methods to prove bioequivalence, though differing guidelines and a new focus on matching reference product structures pose challenges.